News

Patients with psoriasis who show an early response to the biologics risankizumab or guselkumab are more likely to have a long ...
Professor Omar Usmani and Respiratory Effectiveness Group colleagues outline a pragmatic approach to inhaler choice and ...
But are these observations simply a fluke or is there a plausible explanation that could account for the reduced incidence of COVID-19 among smokers?
A new study highlights the risks of atopic dermatitis flare-ups after discontinuing dupilumab and the likelihood of restarting treatment.
Almost one in 10 doctors in the EU intend to leave their profession, highlighting widespread retention issues, the METEOR Project shows.
A study shows that a machine-learning generated treatment plan for patients with prostate cancer, while accurate, was less likely to be used by physicians in practice. Advancements in machine-learning ...
mRNA-4157/V940 which represents a personalised cancer vaccine has been found effective when combined with pembrolizumab in advanced melanoma Moderna, in conjunction with Merck, has found that the ...
Artificial neural networks can be trained to detect bronchopulmonary dysplasia in preterm infants, researchers reported at ERS Congress 2024.
The early use of implantable defibrillators may benefit high-risk heart failure patients with low left ventricular ejection fractions.
RSVpreF a vaccine candidate against respiratory syncytial virus showed a high level of efficacy in older adults with more severe infection Pfizer’s vaccine candidate RSVpreF for respiratory syncytial ...
RPath president Dr Bernie Croal discusses the evolving landscape of pathology in the UK, the challenges and opportunities, and what's next.
A new anti-HER2 IgE antibody potentially offers new therapy options for treatment-resistant breast and ovarian cancers.